ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS MARKET ANALYSIS

Increasing side effects associated with the available drugs such as tigecycline for the treatment of acute bacterial skin and skin structure infections can hamper growth of the global acute bacterial skin and skin structure infections market over the forecast period. For instance, according to the National Institute of Health, U.S., Tigecycline injection have many side effects such as dizziness, vomiting, diarrhea, nausea, headache, pain, itching of the vagina, and others. These side effects may turn into severe symptoms such as heart attack or some forms of cancer.

Market Opportunity – Rising Awareness about Treatment and Prevention

Rising awareness about treatment and prevention could provide significant opportunities for growth in the global acute bacterial skin and skin structure infections market in the near future. Various awareness campaigns by non-profit public health organizations have highlighted the importance of completing the prescribed course of antibiotics and seeking medical advice for recurring or severe symptoms. Rising awareness directly impacts patients' healthcare seeking behavior and compliance with medications. More individuals are now willing to visit a doctor or clinic at the first signs of infection like redness, swelling or pus, rather than adopting an avoidant approach. As a result, infections are caught at an early stage allowing for quicker recovery through appropriate antibiotic therapy. Early detection and management can prevent infections from spreading deeper into tissues or the bloodstream, thus, reducing the need for interventions like surgical drainage or hospitalization.